The Global Multiparameter Patient Monitoring Devices Market is Expected to Grow at a CAGR of 3.5% from 2010 - 2017

Friday 13 January 2012, Amsterdam

The global multiparameter patient monitoring devices market is expected to grow at a Compound Annual Growth Rate (CAGR) of 3.5% from 2010 - 2017. The global multiparameter patient monitoring devices market achieved revenues of $2.9 billion in 2010, which are expected to increase to $3.7 billion by 2017. The increasing target population due to the high prevalence of chronic diseases such as Cardiovascular Diseases (CVD), diabetes, Chronic Obstructive Pulmonary Disease (COPD) and cancer will drive the market growth. The increasing elderly population will result in more incidences of chronic diseases and increased hospitalizations, which will drive the market for multiparameter patient monitoring devices. Healthcare investments in emerging economies in better healthcare infrastructure are also expected to drive this market.

According to the World Health Organization (WHO), the total number of deaths globally due to CVD was 18.1 million in 2010, and is expected to be 20.5 million in 2020 and 24.2 million in 2030. According to the International Diabetes Federation (IDF), the global prevalence of diabetes in 2010 was 6.6% and is expected to increase to 7.8% in 2030. Over 38 million people suffer from COPD in the US, Europe and Japan.


Philips Healthcare and GE Healthcare are the Leaders in the Global Multiparameter Patient Monitoring Devices Market

In 2010, Philips Healthcare was the leader in the global multiparameter patient monitoring devices market with a 38% share, followed by GE Healthcare with 24%. The top two players occupy more than 60% of the global market. Such domination by the major players provides significant barriers for new entrants in the market.

According to GlobalData, the deals scenario is not strong in the multiparameter patient monitoring devices market. The top manufacturers prefer investing capital in product development and expansion in newer geographical regions. Strong product portfolios and a focus on R&D by the major players will result in company shares remaining at a similar level for the near future.


The US is the Largest Market for Multiparameter Patient Monitoring Devices

The US is the largest market for multiparameter patient monitoring devices, accounting for about 47% of the global market. The US multiparameter patient monitoring devices market was valued at $1.4 billion in 2010 and is expected to grow at a CAGR of 2.9% from 2010 through 2017 to reach $1.7 billion.

The demand for physician and clinical services is expected to increase significantly due to the expanded Medicaid and private insurance coverage. The prevalence of chronic diseases is also increasing in the US. These factors will increase the demand for multiparameter patient monitoring devices, since there will be a subsequent increase in hospitalizations. According to the American Cancer Society, about 1.6 million new cancer cases are expected to be diagnosed in 2011.

The high prevalence of other chronic diseases such as diabetes and respiratory disorders such as COPD, will also lead to an increase in the target population for multiparameter patient monitoring devices.
 

Increasing Hospital Admissions to Drive Demand for Multiparameter Patient Monitoring Devices

The multiparameter patient monitoring devices market is expected to be driven by an increasing number of hospitalizations, especially in the US. According to the National Hospital Ambulatory Medical Care Survey, the number of emergency department visits in the US was 123.8 million in 2008. Almost 50% of these visits are by patients in the 25-64 age group.

The demand for high acuity monitors will be driven by increasing admissions to intensive care units (ICUs) because of underlying conditions such as respiratory diseases, ischemic heart disorder, sepsis and heart failure, which are experiencing an increasing trend. The market for mid acuity monitors will benefit from the significant number of emergency department visits. The increasing need for ambulatory and transport monitoring services will drive the demand for low acuity monitors. Larger hospitals will lead the demand for multiparameter central stations.